NASDAQ:KNTE

Kinnate Biopharma News Headlines

$29.64
-1.55 (-4.97 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$28.66
Now: $29.64▼
$31.64
50-Day Range
$26.99
MA: $32.34▼
$37.00
52-Week Range
$24.14
Now: $29.64▼
$48.75
Volume138,483 shs
Average Volume202,050 shs
Market Capitalization$1.29 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Kinnate Biopharma (NASDAQ KNTE) News Headlines Today

SourceHeadline
Q2 2021 Earnings Estimate for Kinnate Biopharma Inc. (NASDAQ:KNTE) Issued By Piper SandlerQ2 2021 Earnings Estimate for Kinnate Biopharma Inc. (NASDAQ:KNTE) Issued By Piper Sandler
americanbankingnews.com - April 1 at 7:50 AM
Q1 2021 EPS Estimates for Kinnate Biopharma Inc. (NASDAQ:KNTE) Decreased by WedbushQ1 2021 EPS Estimates for Kinnate Biopharma Inc. (NASDAQ:KNTE) Decreased by Wedbush
americanbankingnews.com - April 1 at 7:16 AM
Q1 2021 EPS Estimates for Kinnate Biopharma Inc. Lifted by SVB Leerink (NASDAQ:KNTE)Q1 2021 EPS Estimates for Kinnate Biopharma Inc. Lifted by SVB Leerink (NASDAQ:KNTE)
americanbankingnews.com - April 1 at 7:16 AM
Brokers Set Expectations for Kinnate Biopharma Inc.s Q1 2022 Earnings (NASDAQ:KNTE)Brokers Set Expectations for Kinnate Biopharma Inc.'s Q1 2022 Earnings (NASDAQ:KNTE)
americanbankingnews.com - March 31 at 8:46 AM
Kinnate Biopharma (NASDAQ:KNTE) Announces Earnings Results, Beats Estimates By $1.04 EPSKinnate Biopharma (NASDAQ:KNTE) Announces Earnings Results, Beats Estimates By $1.04 EPS
americanbankingnews.com - March 30 at 7:46 AM
Kinnate Biopharma Inc. Reports Full Year 2020 Financial ResultsKinnate Biopharma Inc. Reports Full Year 2020 Financial Results
finance.yahoo.com - March 29 at 7:44 PM
Kinnate Biopharma Inc. Announces Its Addition to the Russell 2000® IndexKinnate Biopharma Inc. Announces Its Addition to the Russell 2000® Index
finance.yahoo.com - March 19 at 4:48 PM
Were Hopeful That Kinnate Biopharma (NASDAQ:KNTE) Will Use Its Cash WiselyWe're Hopeful That Kinnate Biopharma (NASDAQ:KNTE) Will Use Its Cash Wisely
finance.yahoo.com - March 3 at 8:51 AM
Kinnate Biopharma Inc. to Participate in Upcoming Investor ConferencesKinnate Biopharma Inc. to Participate in Upcoming Investor Conferences
finance.yahoo.com - February 11 at 6:15 PM
Kinnate Biopharma, Inc. (KNTE)Kinnate Biopharma, Inc. (KNTE)
realmoney.thestreet.com - December 30 at 10:14 PM
Why SVB Leerink Is Bullish On Kinnate BiopharmaWhy SVB Leerink Is Bullish On Kinnate Biopharma
markets.businessinsider.com - December 28 at 3:44 PM
Kinnate Biopharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters Option to Purchase Additional SharesKinnate Biopharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters' Option to Purchase Additional Shares
benzinga.com - December 7 at 11:06 PM
Kinnate Biopharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional SharesKinnate Biopharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - December 7 at 6:06 PM
Kinnate Biopharma IncKinnate Biopharma Inc
reuters.com - December 6 at 4:48 PM
Kinnate Biopharma Inc. (KNTE)Kinnate Biopharma Inc. (KNTE)
in.finance.yahoo.com - December 4 at 10:17 PM
Biotech IPOs Of Seer, Silverback Jump As Trading Gets UnderwayBiotech IPOs Of Seer, Silverback Jump As Trading Gets Underway
finance.yahoo.com - December 4 at 5:16 PM
Oncology biotech Kinnate Biopharma ups proposed deal size by 25% ahead of $213 million IPOOncology biotech Kinnate Biopharma ups proposed deal size by 25% ahead of $213 million IPO
nasdaq.com - December 3 at 10:28 PM
IPO Alert: Kinnate BiopharmaIPO Alert: Kinnate Biopharma
markets.businessinsider.com - December 3 at 10:28 PM
Kinnate Biopharma to offer 11.5 million shares in planned IPO, priced at $18 to $19 eachKinnate Biopharma to offer 11.5 million shares in planned IPO, priced at $18 to $19 each
marketwatch.com - December 3 at 10:28 PM
Kinnate Biopharma upsizes IPO and prices above range at $20 a shareKinnate Biopharma upsizes IPO and prices above range at $20 a share
msn.com - December 3 at 10:28 PM
Oncology biotech Kinnate Biopharma prices further upsized IPO at $20, above the upwardly revised rangeOncology biotech Kinnate Biopharma prices further upsized IPO at $20, above the upwardly revised range
nasdaq.com - December 3 at 10:28 PM
Kinnate Biopharma stock more than doubles in trading debutKinnate Biopharma stock more than doubles in trading debut
msn.com - December 3 at 10:28 PM
This page was last updated on 4/16/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.